bethanidine

Trade name: tenathan

Small moleculeapproved

Approved

May 29, 1981

Bethanidine is a post-ganglionic adrenergic neurone-blocking agent which exerts a marked postural hypotensive effect. The precise mechanism whereby bethanidine causes blockade of adrenergic neurones is unknown. An initial sympathomimetic effect has been demonstrated in man and animals, possibly due to release of catecholamines. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1980s

  1. May 29, 1981

    AH Robins — Earliest FDA Approval

  2. May 29, 1981

    AH Robins — NDA Organization

Indications

Approved for

Mechanism of action

Approval history

  • approvedMay 29, 1981

Chemistry & pharmacology

Loading structure…

SMILES

CNC(NC)=NCC1=CC=CC=C1
Mol. weight
177.2462 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No
Availability
Discontinued

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bendogen
  • bendogen
  • betanidina
  • betanidina
  • betanidine
  • betanidine
  • betanidine
  • betanidine
  • betanidine
  • betanidine sulfate
  • betanidine sulfate
  • betanidinum
  • betanidinum
  • bethanidine
  • bethanidine
  • bethanidine
  • bethanidine
  • bethanidine
  • bethanidine
  • bethanidine
  • bethanidine sulfate
  • bethanidine sulfate
  • bethanidine sulfate
  • bethanidine sulfate
  • bw-467-c-60
  • bw-467-c-60
  • esbatal
  • esbatal
  • esbatal
  • esbatal
  • esbatal
  • esbatal
  • n,n'-dimethyl-n''-(phenylmethyl)-guanidine
  • n,n'-dimethyl-n''-(phenylmethyl)-guanidine
  • tenathan
  • tenathan
  • tenathan

Organizations

Marketing (1)

OrganizationOrg typeRelationshipDate
AH RobinsFor profitNDAMay 29, 1981